Evoke plc (LON:EVOK – Get Free Report)’s stock price fell 10% during trading on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares traded hands during mid-day trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analysts Forecast Growth
EVOK has been the subject of a number of recent research reports. Berenberg Bank reduced their price objective on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating for the company in a research note on Wednesday, December 4th. Jefferies Financial Group restated a “buy” rating and issued a GBX 140 ($1.81) price target on shares of Evoke in a research note on Monday, December 16th.
Get Our Latest Research Report on EVOK
Evoke Trading Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last announced its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. Equities analysts expect that Evoke plc will post 12.7648305 earnings per share for the current year.
Insiders Place Their Bets
In other Evoke news, insider Andrea Gisle Joosen purchased 14,572 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The shares were purchased at an average cost of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). 27.00% of the stock is owned by company insiders.
About Evoke
Recommended Stories
- Five stocks we like better than Evoke
- What is the Hang Seng index?
- MarketBeat Week in Review – 03/24 – 03/28
- What is Short Interest? How to Use It
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Investing in Commodities: What Are They? How to Invest in Them
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.